What should I do if a patient misses a scheduled dose of, or experiences a gap in their long-acting injectable (LAI) treatment?

Please refer to the appropriate section of the FDA label as listed below for each medication. The label can be found by searching Drugs@FDA at the FDA website. Information is also available using the Drugs@FDA smartphone app.

  • Abilify Maintena (aripiprazole LAI) – Refer to label section 2.2: Dosage Adjustments for Missed Doses
  • Aristada (aripiprazole LAI) – Refer to label section 2.2: Missed Doses
  • Invega Sustenna (paliperidone palmitate LAI) – Refer to label section 2.3: Missed Doses
  • Invega Trinza (paliperidone palmitate LAI) – Refer to label section 2.3: Missed Doses
  • Perseris (risperidone sub-cutaneous LAI) – Refer to label section 2.1: Recommended Dosage

There is no specific guidance from the FDA on how to handle missed doses of the following LAIs:

  • Haldol decanoate (haloperidol LAI)
  • Prolixin decanoate (fluphenazine LAI)
  • Riperdal Consta (risperidone LAI)
If you would like more information on this topic, or would like to provide any feedback, please send us a message using our consultation system: www.smiadviser.org/submit-consult. Be sure to let us know about which tip you are writing. We would love to hear from you, and the consultation system is free to use and confidential. Thank you!
  • Was this Helpful ?
  • YesNo

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts

X